| ORIGINAL ARTICLE |
|
| Year : 2019 | Volume
: 11
| Issue : 2 | Page : 80-82 |
|
|
The largest American study comparing transient elastography and the aminotransferase-to-platelet ratio index score, two noninvasive tests for liver fibrosis staging in HIV/HCV coinfected patients
Jason Dazley1, Elaine Szabela1, A Adebara2, Prerak Shukla1, Raymund Sison1, Jihad Slim1
1 Department of Infectious Diseases, Seton Hall University, NJ, USA
2 Department of Infectious Diseases, St. Michael's Medical Center, NJ, USA
Correspondence Address:
Dr. Jason Dazley
Seton Hall University, 111 Central Avenue, Newark, NJ 07911
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jgid.jgid_10_16
|
|
|
Objective: Elastography has become the standard of care of diagnostic approaches for liver disease, particularly when dealing with hepatitis C. There areno studies in the inner-city populations of Newark, New Jersey, that describe the comparison of noninvasive markers, such as FibroScan andaminotransferase-to-platelet ratio index (APRI) scoring. Methods: Using a chart review method, we used a case-control study method of gathering and analyzing the data, using P < or = 0.05 as a significant variable. Results: The outcome of this study indicates that the FibroScan may be a better marker than the APRI score for the staging of liver disease when a patient has hepatitis B or C with or without HIV/AIDS. Conclusions: This may be a benchmark study to further enhance our understanging of the utility of the fibroscan.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
